Ledger.Open graph →
SEC Form D · filed November 30, 2012

Rib-X Pharmaceuticals, Inc

Offering
$67.5M
Sold
$18.7M
Exemption
—
Industry
Pharmaceuticals
Location
NEW HAVEN, CT
Type
—

People & firms on this filing (13)

Jonathan S. Leff · New Haven, CTDirectorC. Boyd Clarke · New Haven, CTDirectorMark Leuchtenberger · New Haven, CTExec · DirectorCecilia Gonzalo · New Haven, CTDirectorRobert Conerly · New Haven, CTExecHarry H. Penner, Jr · New Haven, CTDirectorWilliam Butler · Denver, COExec · DirectorC. H. Johnson · Denver, COExecStephen C. Byrd · New York, NYDirectorShawn W. Poole · Atlanta, GADirectorSharon Greenbaum · Atlanta, GADirectorAaron Sack · New York, NYDirectorGeorge M. Milne, Jr · BEDFORD, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗